Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Chaisson

Showing results (111-120 of 241) with videos related to

Pageof 25
Sort By:
The Lancet. Infectious Diseases|February 19, 2026
The looming crisis of bedaquiline-resistant tuberculosis and a promising way forwardPauline Howell, Jonathan Stillo, Anja Reuter, et al.
The American Journal on Addictions|September 17, 2004
Gender differences in indices of opioid dependency and medical comorbidity in a population of hospitalized HIV-infected African-AmericansSusan J Boyd, Neena F Thomas-Gosain, Annie Umbricht, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2015
Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness AnalysisAlice A Zwerling, Maitreyi Sahu, Lucky G Ngwira, et al.
Hepatology (Baltimore, Md.)|December 25, 2004
The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfectionShruti H Mehta, David L Thomas, Michael Torbenson, et al.
BMC Infectious Diseases|March 3, 2009
T-SPOT.TB responses during treatment of pulmonary tuberculosisSamantha Ribeiro, Kelly Dooley, Judith Hackman, et al.
Clinical Trials (London, England)|April 26, 2007
Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy interventionLawrence H Moulton, Jonathan E Golub, Betina Durovni, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|May 1, 2014
Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, BrazilValeria Saraceni, Betina Durovni, Solange C Cavalcante, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected PatientsClement G Adu-Gyamfi, Tracy Snyman, Christopher J Hoffmann, et al.
American Journal of Respiratory and Critical Care Medicine|February 14, 2006
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contactsMauro Schechter, Roberto Zajdenverg, Gisely Falco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2014
Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) studyJonathan E Golub, Silvia Cohn, Valeria Saraceni, et al.
Pageof 25

Showing results (111-120 of 241) with videos related to

Sort By:
Pageof 25
The Lancet. Infectious Diseases|February 19, 2026
The looming crisis of bedaquiline-resistant tuberculosis and a promising way forwardPauline Howell, Jonathan Stillo, Anja Reuter, et al.
The American Journal on Addictions|September 17, 2004
Gender differences in indices of opioid dependency and medical comorbidity in a population of hospitalized HIV-infected African-AmericansSusan J Boyd, Neena F Thomas-Gosain, Annie Umbricht, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2015
Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness AnalysisAlice A Zwerling, Maitreyi Sahu, Lucky G Ngwira, et al.
Hepatology (Baltimore, Md.)|December 25, 2004
The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfectionShruti H Mehta, David L Thomas, Michael Torbenson, et al.
BMC Infectious Diseases|March 3, 2009
T-SPOT.TB responses during treatment of pulmonary tuberculosisSamantha Ribeiro, Kelly Dooley, Judith Hackman, et al.
Clinical Trials (London, England)|April 26, 2007
Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy interventionLawrence H Moulton, Jonathan E Golub, Betina Durovni, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|May 1, 2014
Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, BrazilValeria Saraceni, Betina Durovni, Solange C Cavalcante, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected PatientsClement G Adu-Gyamfi, Tracy Snyman, Christopher J Hoffmann, et al.
American Journal of Respiratory and Critical Care Medicine|February 14, 2006
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contactsMauro Schechter, Roberto Zajdenverg, Gisely Falco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2014
Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) studyJonathan E Golub, Silvia Cohn, Valeria Saraceni, et al.
Pageof 25